Centrally acting agents like phentermine/topiramate and naltrexone/bupropion aid weight reduction but lack MASLD-specific data and carry potential risks such as hepatotoxicity, teratogenicity, or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback